Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
With
AbbVie
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Participated in a previous elotuzumab protocol (including, but not limited to HuLuc63-1703, CA204007, CA204009, or CA204011) and is deemed by the investigator to be deriving benefit from elotuzumab and/or other study drugs as defined by the previous protocol
Receiving elotuzumab and/or other study drugs at the time of signature of informed consent
Males and Females, ages 18 and older
You may not be if
All participants previously discontinued from an elotuzumab study for any reason
Participants not receiving clinical benefit from previous study therapy
Participants who are not medically well enough to receive study therapy as determined by the investigator
Clareo Health | Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab
